Drug Type Chemical drugs |
Synonyms FLLL-62 |
Target |
Action inhibitors |
Mechanism STAT3 inhibitors(Signal transducer and activator of transcription 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Melanoma | Preclinical | United States | 10 Aug 2012 | |
| Renal Cell Carcinoma | Preclinical | United States | 10 Aug 2012 |





